Logo image of CLA.PA

CLARANOVA SE (CLA.PA) Stock Fundamental Analysis

EPA:CLA - Euronext Paris - Matif - FR0013426004 - Common Stock - Currency: EUR

2.22  -0.02 (-0.89%)

Fundamental Rating

4

Overall CLA gets a fundamental rating of 4 out of 10. We evaluated CLA against 99 industry peers in the Software industry. There are concerns on the financial health of CLA while its profitability can be described as average. CLA scores decently on growth, while it is valued quite cheap. This could make an interesting combination.


Dividend Valuation Growth Profitability Health

Quickly go to:

4

1. Profitability

1.1 Basic Checks

In the past year CLA has reported negative net income.
CLA had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: CLA reported negative net income in multiple years.
In the past 5 years CLA always reported a positive cash flow from operatings.
CLA.PA Yearly Net Income VS EBIT VS OCF VS FCFCLA.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M -40M

1.2 Ratios

The Return On Assets of CLA (-1.14%) is comparable to the rest of the industry.
CLA had an Average Return On Invested Capital over the past 3 years of 17.26%. This is significantly above the industry average of 10.83%.
The last Return On Invested Capital (%ROIC%%) for CLA is well below the 3 year average (17.26%), which needs to be investigated, but indicates that CLA had better years and this may not be a problem.
Industry RankSector Rank
ROA -1.14%
ROE N/A
ROIC N/A
ROA(3y)-4.27%
ROA(5y)-1.67%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)17.26%
ROIC(5y)13.84%
CLA.PA Yearly ROA, ROE, ROICCLA.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500 -500 -1K

1.3 Margins

The Operating Margin of CLA (8.86%) is better than 61.62% of its industry peers.
In the last couple of years the Operating Margin of CLA has grown nicely.
CLA has a Gross Margin of 29.19%. This is in the lower half of the industry: CLA underperforms 75.76% of its industry peers.
CLA's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 8.86%
PM (TTM) N/A
GM 29.19%
OM growth 3Y14.65%
OM growth 5Y11.6%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y5.23%
GM growth 5Y1.62%
CLA.PA Yearly Profit, Operating, Gross MarginsCLA.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20 -20

More info and screens

2

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), CLA is creating value.
Compared to 1 year ago, CLA has more shares outstanding
CLA has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, CLA has an improved debt to assets ratio.
CLA.PA Yearly Shares OutstandingCLA.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
CLA.PA Yearly Total Debt VS Total AssetsCLA.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

2.2 Solvency

CLA has an Altman-Z score of 0.68. This is a bad value and indicates that CLA is not financially healthy and even has some risk of bankruptcy.
CLA has a Altman-Z score of 0.68. This is in the lower half of the industry: CLA underperforms 75.76% of its industry peers.
The Debt to FCF ratio of CLA is 5.38, which is a neutral value as it means it would take CLA, 5.38 years of fcf income to pay off all of its debts.
With a Debt to FCF ratio value of 5.38, CLA perfoms like the industry average, outperforming 59.60% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 5.38
Altman-Z 0.68
ROIC/WACCN/A
WACC8%
CLA.PA Yearly LT Debt VS Equity VS FCFCLA.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M

2.3 Liquidity

CLA has a Current Ratio of 0.50. This is a bad value and indicates that CLA is not financially healthy enough and could expect problems in meeting its short term obligations.
CLA has a worse Current ratio (0.50) than 83.84% of its industry peers.
CLA has a Quick Ratio of 0.50. This is a bad value and indicates that CLA is not financially healthy enough and could expect problems in meeting its short term obligations.
CLA has a worse Quick ratio (0.45) than 85.86% of its industry peers.
Industry RankSector Rank
Current Ratio 0.5
Quick Ratio 0.45
CLA.PA Yearly Current Assets VS Current LiabilitesCLA.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

More info and screens

4

3. Growth

3.1 Past

CLA shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 34.81%, which is quite impressive.
CLA shows a decrease in Revenue. In the last year, the revenue decreased by -0.95%.
Measured over the past years, CLA shows a quite strong growth in Revenue. The Revenue has been growing by 13.58% on average per year.
EPS 1Y (TTM)34.81%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%497.85%
Revenue 1Y (TTM)-0.95%
Revenue growth 3Y1.74%
Revenue growth 5Y13.58%
Sales Q2Q%-2.36%

3.2 Future

CLA is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 42.75% yearly.
The Revenue is expected to grow by 3.22% on average over the next years.
EPS Next Y89.09%
EPS Next 2Y57.25%
EPS Next 3Y42.75%
EPS Next 5YN/A
Revenue Next Year-1.82%
Revenue Next 2Y2.02%
Revenue Next 3Y3.22%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
CLA.PA Yearly Revenue VS EstimatesCLA.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 100M 200M 300M 400M 500M
CLA.PA Yearly EPS VS EstimatesCLA.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 0.2 -0.2 0.4

More info and screens

7

4. Valuation

4.1 Price/Earnings Ratio

CLA reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Based on the Price/Forward Earnings ratio of 6.46, the valuation of CLA can be described as very cheap.
Based on the Price/Forward Earnings ratio, CLA is valued cheaper than 98.99% of the companies in the same industry.
CLA is valuated cheaply when we compare the Price/Forward Earnings ratio to 35.19, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE N/A
Fwd PE 6.46
CLA.PA Price Earnings VS Forward Price EarningsCLA.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40 60

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, CLA is valued cheaper than 97.98% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, CLA is valued cheaper than 100.00% of the companies in the same industry.
Industry RankSector Rank
P/FCF 4.22
EV/EBITDA 3.48
CLA.PA Per share dataCLA.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4 6 8

4.3 Compensation for Growth

CLA's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
CLA's earnings are expected to grow with 42.75% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y57.25%
EPS Next 3Y42.75%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for CLA!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CLARANOVA SE

EPA:CLA (7/14/2025, 11:42:26 AM)

2.22

-0.02 (-0.89%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)05-13 2025-05-13
Earnings (Next)07-31 2025-07-31/amc
Inst Owners4.7%
Inst Owner ChangeN/A
Ins Owners5.02%
Ins Owner ChangeN/A
Market Cap127.01M
Analysts80
Price Target3.77 (69.82%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)7.25%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-8.23%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-2.26%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 6.46
P/S 0.26
P/FCF 4.22
P/OCF 3.44
P/B N/A
P/tB N/A
EV/EBITDA 3.48
EPS(TTM)-0.08
EYN/A
EPS(NY)0.34
Fwd EY15.47%
FCF(TTM)0.53
FCFY23.7%
OCF(TTM)0.64
OCFY29.05%
SpS8.54
BVpS-0.3
TBVpS-2.29
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -1.14%
ROE N/A
ROCE -2165%
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM 8.86%
PM (TTM) N/A
GM 29.19%
FCFM 6.16%
ROA(3y)-4.27%
ROA(5y)-1.67%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)17.26%
ROIC(5y)13.84%
ROICexc(3y)46.34%
ROICexc(5y)36.95%
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)23.49%
ROCE(5y)18.83%
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3Y3.39%
ROICexc growth 5Y10.18%
OM growth 3Y14.65%
OM growth 5Y11.6%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y5.23%
GM growth 5Y1.62%
F-Score7
Asset Turnover1.69
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 5.38
Debt/EBITDA 0.21
Cap/Depr 55.74%
Cap/Sales 1.39%
Interest Coverage 250
Cash Conversion 66.49%
Profit Quality N/A
Current Ratio 0.5
Quick Ratio 0.45
Altman-Z 0.68
F-Score7
WACC8%
ROIC/WACCN/A
Cap/Depr(3y)51.75%
Cap/Depr(5y)41.72%
Cap/Sales(3y)1.22%
Cap/Sales(5y)0.95%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)34.81%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%497.85%
EPS Next Y89.09%
EPS Next 2Y57.25%
EPS Next 3Y42.75%
EPS Next 5YN/A
Revenue 1Y (TTM)-0.95%
Revenue growth 3Y1.74%
Revenue growth 5Y13.58%
Sales Q2Q%-2.36%
Revenue Next Year-1.82%
Revenue Next 2Y2.02%
Revenue Next 3Y3.22%
Revenue Next 5YN/A
EBIT growth 1Y22.32%
EBIT growth 3Y16.65%
EBIT growth 5Y26.75%
EBIT Next Year25.23%
EBIT Next 3Y14.42%
EBIT Next 5YN/A
FCF growth 1Y323.94%
FCF growth 3Y32.3%
FCF growth 5Y48.99%
OCF growth 1Y212.71%
OCF growth 3Y28.52%
OCF growth 5Y40.7%